amlitelimab IV (SAR445229) - Sanofi
Ebglyss (lebrikizumab) - Eli Lilly
rademikibart (CBP-201) - Suzhou Connect Biopharma
Vtama (tapinarof) - Roivant
rocatinlimab (KHK4083) - Amgen
B244 topical - AOBiome
Mitchga (nemolizumab) - Galderma
http://www.ncbi.nlm.nih.gov/pubmed/38662529
 
Albert C Chong; Malcolm Su; Ogechi Obed; Peck Y Ong
 
Apr 25, 2024
 
Next